PORTAL EX3 Trademark

Trademark Overview

On Thursday, May 30, 2024, a trademark application was filed for PORTAL EX3 with the United States Patent and Trademark Office. The USPTO has given the PORTAL EX3 trademark a serial number of 98575895. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 30, 2024. This trademark is owned by Portal Innovations, LLC. The PORTAL EX3 trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting services for start-up companies; Assistance, advisory services and consultancy with regard to business planning, business management, and business operations for biotech companies
portal ex3

General Information

Serial Number98575895
Word MarkPORTAL EX3
Filing DateThursday, May 30, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, May 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBusiness consulting services for start-up companies; Assistance, advisory services and consultancy with regard to business planning, business management, and business operations for biotech companies

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePortal Innovations, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60607

Trademark Events

Event DateEvent Description
Thursday, May 30, 2024NEW APPLICATION ENTERED

Related Keywords

portal business companies services planning management operations biotech regard advisory consulting